Nitrate Modulates Cognitive Impairment Via Oral Microbiota.
The Effect of Nitrate on Cognitive Function in Alcohol Dependence Patients and the Potential Microbiota Mechanism.
1 other identifier
interventional
70
1 country
1
Brief Summary
Alcohol use is increasingly prevalent in modern society and is known to cause cognitive impairment and dysregulation of inflammatory responses. In the present study, the investigators want to perform a randomised controlled trials to test whether nitrate could change the oral microbiota and benefit the cognitive impairment in alcohol dependence patients. The investigators survey the oral bacterial communities in saliva samples of 70 alcohol dependent patients following 14 days of dietary inorganic nitrate (nitrate-rich beetroot juice, \~750 mg NO3- /d) and placebo (nitrate-depleted beetroot juice, \~1 mg NO3- /d) supplementation.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Sep 2023
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 30, 2023
CompletedFirst Posted
Study publicly available on registry
July 27, 2023
CompletedStudy Start
First participant enrolled
September 10, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 7, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
August 7, 2024
CompletedJune 3, 2025
May 1, 2025
11 months
June 30, 2023
May 28, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Changes of Delayed Match to Sample Percent Correct (all delays) from baseline to post-intervention
Test by DMS-PCAD (Delayed Match to Sample Percent Correct , all delays)
baseline and post-intervention(two weeks after baseline test)
Changes of Spatial Working Memory Between Errors from baseline to post-intervention
Test by SWM-BE (The Spatial Working Memory Between Errors )
baseline and post-intervention(two weeks after baseline test)
Secondary Outcomes (20)
Changes of oral microbiota from baseline to post-intervention
baseline and post-intervention(two weeks after baseline test)
Changes of gut microbiota from baseline to post-intervention
baseline and post-intervention(two weeks after baseline test)
Changes of Delayed Match to Sample Percent Correct (0 seconds delay) from baseline to post-intervention
baseline and post-intervention(two weeks after baseline test)
Changes of Delayed Match to Sample Percent Correct (4 seconds delay) from baseline to post-intervention
baseline and post-intervention(two weeks after baseline test)
Changes of Delayed Match to Sample Percent Correct (12 seconds delay) from baseline to post-intervention
baseline and post-intervention(two weeks after baseline test)
- +15 more secondary outcomes
Other Outcomes (7)
Systolic and diastolic blood pressure
baseline and post-intervention (two weeks after baseline test)
Cytokine Tumor Necrosis Factor-a in serum
baseline and post-intervention(two weeks after baseline test)
The blood biochemical related parameters includes liver enzymes (alanine aminotransferase and aspartate aminotransferase)
baseline and post-intervention (two weeks after baseline test)
- +4 more other outcomes
Study Arms (2)
Group N
EXPERIMENTALGroup P
PLACEBO COMPARATORInterventions
nitrate-depleted beetroot juice, \~1 mg NO3- /d
Eligibility Criteria
You may qualify if:
- Han nationality
- Montreal Cognitive Assessment(MoCA) score \>11
- Diagnosis of alcohol dependence
You may not qualify if:
- Past or current infectious disease
- Past or current heart, brain, liver, kidney, and other severe diseases
- Past or current metabolic diseases that can lead to abnormalities of the immune system, such as obesity (Body Mass Index \> 30 kg/m2), diabetes, or rheumatoid arthritis
- Past or current neurodegenerative diseases, such as Parkinson's disease
- Use of steroidal and non-steroidal anti-inflammatory drugs, antibiotics, antioxidants, and immunosuppressive agents within two months of enrollment
- Use of probiotics and probiotics every day for the first two months before enrollment
- Previous or current DSM-IV diagnosis of schizophrenia, depression, anxiety disorder, bipolar disorder, mental retardation, dementia (excluding mild cognitive impairment, MCI), or substance dependence other than alcohol and nicotine
- Irregular eating habits that affect the oral flora (except alcohol) in the previous two months
- Current oral disease
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Anhui mental health center
Hefei, Anhui, 230022, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Hongqiang Sun
Peking University Sixth Hospital
- STUDY CHAIR
Liangjun Pang
Anhui mental health central
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Clinical Professor,Director
Study Record Dates
First Submitted
June 30, 2023
First Posted
July 27, 2023
Study Start
September 10, 2023
Primary Completion
August 7, 2024
Study Completion
August 7, 2024
Last Updated
June 3, 2025
Record last verified: 2025-05
Data Sharing
- IPD Sharing
- Will not share